On behalf of the Board of Directors of The LAM Foundation, I am delighted to announce that after an extensive national search, the Board has unanimously selected Sally Draper as The LAM Foundation’s new Executive Director, effective August 19, 2024. Sally brings more than twenty-five years of executive experience in the nonprofit sector, with a proven track record of strategic growth, program development, and community engagement. Most recently she served as Senior Vice President and Executive Director of The Rosecrance Foundation at Rosecrance Behavioral Health, one of the Midwest’s largest nonprofit behavioral health networks, where she was a key member of the executive leadership team, which is responsible for overseeing operational success across treatment services, advocacy, marketing, business development, HR, finance, and fundraising.

In her previous role with the American Lung Association, Sally gained extensive experience working with both pharmaceutical and industry partners on several rare lung diseases. We are eager to leverage her knowledge and experience to benefit LAM patients worldwide.

Sally’s passion for advocacy, research, and education, combined with her innovative approaches to strategy, development, and relationship-building, make her an ideal fit to lead our organization into its next chapter. She holds a BA with Honors from Princeton University and has been recognized with numerous professional awards, including the SABRE Award in the Marketing to Senior Category for the 2019 and 2020 Flu Season. In her own words: “I have been increasingly excited about the promise and potential of LAM research, as well as the possibilities for increased patient and caregiver engagement and support. It is tremendously exciting to think about the international implications of the clinical network and the positioning of the organization among leading women’s health organizations and brands.”

We are confident that under Sally’s leadership, The LAM Foundation will continue to thrive and expand our impact on LAM research. We plan to host a virtual welcome reception in the fall to give our LAM community an opportunity to meet Sally. We look forward to introducing her to you all and to the exciting road ahead for The LAM Foundation as we further our mission to seek safe and effective treatments and ultimately a cure for lymphangioleiomyomatosis (LAM). Please join me in extending a warm welcome to Sally Draper.

Sincerely,

Chuck Wehland
Board Chair, The LAM Foundation